At Genentech, a member of the Roche Group, the Green BioPharma program aims to bring sustainability into R&D labs.
Green BioPharma is an extension of the group-wide Green Chemistry program and focuses on the design, development and implementation of biological and chemical products and processes that reduce or eliminate the use and generation of substances hazardous to human health and the environment. We spoke to Green BioPharma Program Manager Kristi Budzinski to find out more.
What was the main catalyst for the scheme?
The catalyst was really employee interest. Our employees are very engaged in sustainability and wanted to merge that with the scientific work they do. We hosted a ‘lunch and learn’ session on Green Chemistry, which further piqued employee interest in having a scientific approach to greening R&D. As Genentech became more integrated with Roche, we became more active in their technical working group on Green Chemistry and wanted to develop a similar program for large molecules, giving rise to Green BioPharma.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine